beta-adrenergic receptors — Drug Target

All drugs that target beta-adrenergic receptors — marketed and clinical-stage. Includes 5 drug classes acting on this target.

Drug classes

Beta-adrenergic agonist · Beta-blocker · beta-blocker · Non-selective beta-adrenergic receptor blocker · nonselective beta blocker

Marketed (3)

• ISOPROTERENOL · Beta-adrenergic agonist · Cardiovascular
  Isoproterenol activates beta-adrenergic receptors without affecting alpha-adrenergic receptors.
• Non arotinolol group · Sumitomo Pharma (Suzhou) Co., Ltd. · Beta-blocker · Cardiovascular
  Non-arotinolol group refers to beta-blockers that are structurally distinct from arotinolol, used primarily for cardiovascular conditions.
• Generic B · University of Florida · beta-blocker · Cardiovascular
  Generic B is a beta-blocker that works by blocking the effects of the hormone epinephrine, also known as adrenaline, and slowing the heart rate and reducing its workload.

Phase 3 pipeline (4)

• timolol 0.5% BID · Inotek Pharmaceuticals Corporation · Non-selective beta-adrenergic receptor blocker · Ophthalmology
  Timolol is a non-selective beta-adrenergic receptor blocker that reduces intraocular pressure by decreasing aqueous humor production and increasing uveoscleral outflow.
• Propranolol Oral Product · University Hospital, Toulouse · beta-blocker · Cardiovascular
  Propranolol is a beta-blocker that works by blocking the action of certain natural chemicals in your body, such as epinephrine, on the heart and blood vessels.
• nonselective beta blocker · Sherief Abd-Elsalam · nonselective beta blocker · Cardiovascular
  Blocks the action of beta-adrenergic receptors, leading to decreased heart rate and blood pressure.
• Timolol + LCP · Centre Hospitalier Universitaire de Nice · Beta-blocker · Cardiovascular
  Timolol is a non-selective beta-adrenergic receptor blocker, and LCP is a beta-blocker.